HeartBeam, Inc. (BEAT)
$0.42-12.50%Close
BUYCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $14M
- Beta
- -0.77
- P/E (TTM)
- -1.12
- Short % float
- 9.02%
- Days to cover
- 6.2
- SI change
- +17.4%
- 1W
- -35.38%
- 1M
- +2.44%
- vs SPY 1W
- -35.81%
- vs SPY 1M
- +0.38%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 5
- VALUE
- 7
- GROWTH
- 39
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-190.8%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-1.12
P/E FWD-
SECTOR PE20.54
INDUSTRY PE10.75
P/B3.77
P/FCF-
EV/EBITDA-1.17
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO3.66
ND/EBITDA-
BETA-0.77
Company news
FAQ
- What is LOPJLB’s current signal on BEAT?
- LOPJLB’s latest quantitative signal on HeartBeam, Inc. (BEAT) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is BEAT in?
- HeartBeam, Inc. (BEAT) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does HeartBeam, Inc. (BEAT) do?
- HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Bran…